Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Rutherford

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Epidemiology|August 24, 2020
Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studiesPaul C Lambert, Therese M-L Andersson, Mark J Rutherford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2025
Monitoring temporal trends in cancer survival; choosing appropriate standards when accounting for age and other-cause mortality variation over timePaul C Lambert, Therese M L Andersson, Tor Åge Myklebust, et al.
British Journal of Cancer|December 14, 2024
The long-lasting impacts of the COVID-19 pandemic on population-based cancer survival: what are the implications for data analysis?Rachael Stannard, Paul C Lambert, Georgios Lyratzopoulos, et al.
MDM Policy & Practice|June 15, 2026
Evaluating the Impact of Different Natural History Modeling Methods on Cost-Effectiveness Decisions: A Case Study in Duchenne Muscular DystrophyJonathan Broomfield, Keith R Abrams, Michael J Crowther, et al.
BJS Open|March 26, 2025
Regional variation in non-traumatic major lower limb amputation in England: observational study of linked primary and secondary care dataAnna Meffen, Mark J Rutherford, Rob D Sayers, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 14, 2023
Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A TutorialMichael J Sweeting, Mark J Rutherford, Dan Jackson, et al.
Statistics in Medicine|September 14, 2023
Using temporal recalibration to improve the calibration of risk prediction models in competing risk settings when there are trends in survival over timeSarah Booth, Sarwar I Mozumder, Lucinda Archer, et al.
BMJ Oncology|May 7, 2026
Estimating the impact of cancer diagnosis on life expectancy by stage at diagnosis: population-based estimates for a range of cancer sites in EnglandRachael Stannard, Paul C Lambert, Therese M-L Andersson, et al.
Breast (Edinburgh, Scotland)|March 25, 2019
Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated - Three what-if scenariosHannah Bower, Therese M-L Andersson, Elisavet Syriopoulou, et al.
British Journal of Cancer|May 12, 2020
Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a VICORI studyCatherine A Welch, Michael J Sweeting, Paul C Lambert, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Epidemiology|August 24, 2020
Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studiesPaul C Lambert, Therese M-L Andersson, Mark J Rutherford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2025
Monitoring temporal trends in cancer survival; choosing appropriate standards when accounting for age and other-cause mortality variation over timePaul C Lambert, Therese M L Andersson, Tor Åge Myklebust, et al.
British Journal of Cancer|December 14, 2024
The long-lasting impacts of the COVID-19 pandemic on population-based cancer survival: what are the implications for data analysis?Rachael Stannard, Paul C Lambert, Georgios Lyratzopoulos, et al.
MDM Policy & Practice|June 15, 2026
Evaluating the Impact of Different Natural History Modeling Methods on Cost-Effectiveness Decisions: A Case Study in Duchenne Muscular DystrophyJonathan Broomfield, Keith R Abrams, Michael J Crowther, et al.
BJS Open|March 26, 2025
Regional variation in non-traumatic major lower limb amputation in England: observational study of linked primary and secondary care dataAnna Meffen, Mark J Rutherford, Rob D Sayers, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 14, 2023
Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A TutorialMichael J Sweeting, Mark J Rutherford, Dan Jackson, et al.
Statistics in Medicine|September 14, 2023
Using temporal recalibration to improve the calibration of risk prediction models in competing risk settings when there are trends in survival over timeSarah Booth, Sarwar I Mozumder, Lucinda Archer, et al.
BMJ Oncology|May 7, 2026
Estimating the impact of cancer diagnosis on life expectancy by stage at diagnosis: population-based estimates for a range of cancer sites in EnglandRachael Stannard, Paul C Lambert, Therese M-L Andersson, et al.
Breast (Edinburgh, Scotland)|March 25, 2019
Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated - Three what-if scenariosHannah Bower, Therese M-L Andersson, Elisavet Syriopoulou, et al.
British Journal of Cancer|May 12, 2020
Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a VICORI studyCatherine A Welch, Michael J Sweeting, Paul C Lambert, et al.
Pageof 8